Snyder–Robinson syndrome
| Snyder–Robinson syndrome | |
|---|---|
| Synonyms | SRS |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Intellectual disability, hypotonia, osteoporosis, scoliosis, kyphosis, seizures, speech delay, facial asymmetry, long face, prominent lower lip |
| Complications | N/A |
| Onset | Infancy |
| Duration | Lifelong |
| Types | N/A |
| Causes | Genetic mutation in the SMS gene |
| Risks | Family history |
| Diagnosis | Genetic testing, clinical evaluation |
| Differential diagnosis | Other forms of intellectual disability and skeletal dysplasia |
| Prevention | N/A |
| Treatment | Supportive care, physical therapy, occupational therapy, speech therapy, seizure management |
| Medication | N/A |
| Prognosis | Variable, depends on severity of symptoms |
| Frequency | Rare disease |
| Deaths | Not typically life-threatening |
Snyder–Robinson Syndrome
Snyder–Robinson syndrome (SRS) is a rare genetic disorder characterized by intellectual disability, muscle and bone abnormalities, and other systemic manifestations. It is an X-linked recessive condition, meaning it primarily affects males, while females are typically carriers.
Genetics[edit]
Snyder–Robinson syndrome is caused by mutations in the SMS gene, which encodes the enzyme spermine synthase. This enzyme is crucial in the polyamine biosynthesis pathway, responsible for converting spermidine into spermine. Polyamines like spermine are essential for cellular growth, differentiation, and stability. The SMS gene is located on the X chromosome at Xp22.11. Mutations in this gene lead to a deficiency of spermine synthase, resulting in an imbalance of polyamines, which is thought to underlie the clinical features of the syndrome.
Clinical Features[edit]
Individuals with Snyder–Robinson syndrome typically present with:
- Intellectual Disability: Ranging from mild to severe, often accompanied by speech delays.
- Hypotonia: Reduced muscle tone, which can affect motor skills.
- Osteoporosis: Increased bone fragility, leading to frequent fractures.
- Facial Dysmorphism: Distinctive facial features may include a prominent forehead, deep-set eyes, and a prominent jaw.
- Seizures: Some individuals may experience epileptic seizures.
- Other Features: These can include kyphoscoliosis, a high-arched palate, and growth retardation.
Diagnosis[edit]
Diagnosis of Snyder–Robinson syndrome is based on clinical evaluation, family history, and genetic testing. Molecular genetic testing can confirm the diagnosis by identifying mutations in the SMS gene.
Management[edit]
There is currently no cure for Snyder–Robinson syndrome. Management is symptomatic and supportive, focusing on:
- Educational Support: Special education programs tailored to the individual's needs.
- Physical Therapy: To improve muscle tone and motor skills.
- Orthopedic Interventions: For managing bone abnormalities and fractures.
- Seizure Management: Antiepileptic drugs may be prescribed for seizure control.
Prognosis[edit]
The prognosis for individuals with Snyder–Robinson syndrome varies depending on the severity of symptoms. With appropriate management, individuals can lead fulfilling lives, although they may require lifelong support.
Research[edit]
Ongoing research aims to better understand the pathophysiology of Snyder–Robinson syndrome and explore potential therapeutic interventions. Studies are focusing on the role of polyamines in cellular processes and how their imbalance affects individuals with the syndrome.
Also see[edit]
| Genetic disorders relating to deficiencies of transcription factor or coregulators | ||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NIH genetic and rare disease info[edit]
Snyder–Robinson syndrome is a rare disease.
| Rare and genetic diseases | ||||||
|---|---|---|---|---|---|---|
|
Rare diseases - Snyder–Robinson syndrome
|
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian